Linda Duska, MD
Gynecologic Oncology · Charlottesville, VANPI 1447241807
Payments from drug & device makers
Across 376 payments — averaging $19,717 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$3.4M
- GSK$1.2M
- AstraZeneca$670K
- Blueprint Medicines Corporation$421K
- Novartis$390K
- Eisai Inc.$265K
- plus $1M from 14 others
Across 1 payment — averaging $2750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- NX Development Corp.$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 85 | $3,426,500 |
| GSK | 87 | $1,195,895 |
| AstraZeneca | 7 | $670,342 |
| Blueprint Medicines Corporation | 27 | $420,689 |
| Novartis | 5 | $390,082 |
| Eisai Inc. | 27 | $265,366 |
| Seagen Inc. | 30 | $252,091 |
| Iovance Biotherapeutics, Inc. | 13 | $209,719 |
| Corcept Therapeutics | 29 | $162,312 |
| Sanofi US Services Inc. | 12 | $150,439 |
| Tesaro, Inc. | 15 | $95,703 |
| Pfizer | 4 | $67,179 |
| Karyopharm Therapeutics Inc. | 21 | $50,583 |
| Immunogen, Inc. | 1 | $31,400 |
| Genmab A/s | 1 | $9,100 |
| AbbVie | 3 | $8,790 |
| Aadi Bioscience, Inc. | 5 | $5,232 |
| Regeneron | 1 | $2,085 |
| Genentech USA, Inc. | 1 | $105 |
| Intuitive Surgical | 2 | $24 |
How this compares
$7,413,636 in reported general payments places this provider in the 95th percentile of 47 gynecologic oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Charlottesville
- Marilyn HuangCharlottesville$3.8M
- Charles LandenCharlottesville$307K
- Kari RingCharlottesville$276K
- Susan ModesittCharlottesville$177K
- Samantha BatmanCharlottesville$76K
- Leigh CantrellCharlottesville$460
- Jaime KiffCharlottesville$82
- Leslie RandallFairfax$2.1M
- Michael McCollumNorfolk$848K
- Cecelia BoardmanRichmond$632K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.